Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference19 articles.
1. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L et al (2021) Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 80(7):930–942
2. Bakasis A-D, Mavragani CP, Boki KA, Tzioufas AG, Vlachoyiannopoulos PG, Stergiou IE et al (2021) COVID-19 infection among autoimmune rheumatic disease patients: data from an observational study and literature review. J Autoimmun 123:102687
3. Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, El Mahou S et al (2021) COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol 3(6):e419–e426
4. Spelman T, Forsberg L, McKay K, Glaser A, Hillert J (2021) Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: a study of the Swedish multiple sclerosis registry. Mult Scler J 2:135245852110262
5. Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M et al (2014) The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48–49:46–49
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献